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1. Introduction 
Bronchiectasis is pathologically defined as a condition in which there are abnormal and 
permanent dilatations of proximal bronchi with predominance at the level of the second to 
the sixth bronchial division. This definition differentiates true bronchiectasis from functional 
bronchiectasis or pseudobronchiectasis, which is expected to return to normal once control 
of infection has been achieved (Deslauriers et al., 1998). Bronchiectasis was first described by 
Laenec in 1819 and, before the antibiotic era, was considered a morbid disease with a high 
mortality rate from respiratory failure and cor pulmonale (Balkanli et al., 2003). With the 
development of antibiotics in the 1940s, this entity began to be seen less frequently, but, with 
the emergence of drug-resistant microorganisms and the increasing frequency of drug-
resistant tuberculosis, an increased incidence of postinfectious bronchiectasis is being noted 
(Miller, 2000). The current increase in tuberculosis rates is directly related to insufficient and 
irregular medication. Additionally, irregular and inadequate treatment, the cessation of 
medication shortly after symptom improvement, and a lack of check-ups after treatment are 
factors accelerating recurrent pulmonary infection in developing countries. As the disease 
progresses, physical activities become increasingly limited, patients fail to thrive, and 
ultimately they suffer from social deprivation, intrinsic depression, and respiratory failure 
(Al-Kattan et al., 2005). Therefore, bronchiectasis is still a major cause of morbidity and 
mortality in developing countries.   
2. Pathophysiology 
Reid categorized bronchiectasis as having three main phenotypes: 1) tubular characterized 
by smooth dilation of the bronchi; 2) varicose in which the bronchi are dilated with multiple 
indentations; and 3) cystic in which dilated bronchi terminate in blind ending sacs (Reid, 
1950). The current major form seen on High resolution computed tomography scanning 
(HRCT) is the tubular form of bronchiectasis. The most definitive study of the pathology of 
bronchiectasis was performed by Whitwell (Whitwell, 1952). Whitwell suggested that 
bronchiectasis should be divided into (1) follicular bronchiectasis, characterized by excessive 
formation of lymphoid tissue both in the walls of dilated bronchi and in enlarged lymph 
nodes and thought to be sequelae of whooping cough, measles, or bronchopneumonia, (2) 
saccular bronchiectasis, characterized by loss of bronchial structures in the sacculi and of 
alveoli around them, and (3) atelectatic bronchiectasis, in which lung collapse leads to 
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bronchiectasis. Follicular bronchiectasis was the dominant form and this corresponded to 
tubular bronchiectasis. In his study, he demonstrated marked inflammation of the bronchial 
wall, principally in the smaller airways. Bronchial dilation was characterized by 
deficiency/loss of elastin and more advance disease by destruction of muscle and cartilage. 
There was variable bronchial wall fibrosis, atelectasis and peribronchial pneumonic change 
(King, 2009). 
Follicular bronchiectasis was characterized by the presence of lymphoid follicles in the 
bronchial wall. The inflammatory process commenced in the small airway. This small 
airway inflammation caused the release of mediators such as proteases which damaged the 
large airways causing loss of elastin and other components such as muscle and cartilage 
which resulted in bronchial dilation. With progression of the disease lymphoid follicles 
enlarged in size and caused airflow obstruction to the small airways. The final event was 
spread of the inflammation beyond the airways to cause interstitial pneumonia (King, 2009). 
The dominant cell types involved in the inflammatory process in bronchiectasis are 
neutrophils, lymphocytes, and macrophages. Neutrophils are the most prominent cell type 
in the bronchial lumen (Loukide et al., 2002; Khair et al., 1996) and release mediators, 
particularly proteases/elastase which cause bronchial dilation (Khair et al., 1996; Zheng et 
al., 2000). The infiltrate in the cell wall is predominantly composed of macrophages and 
lymphocytes (Loukide et al., 2002; Lapa a Silva et al., 1989) 
Bronchiectasis can occur as focal or localized disease, or in a diffuse manner. Localized 
bronchiectasis is usually the result of childhood pneumonia and often has a benign course 
characterized by recurrent pulmonary infections always in the same anatomic territory. By 
contrast, diffuse bronchiectasis is often related to immune deficiencies, is bilateral, and may 
lead to death from respiratory failure (Deslauriers et al., 1998). Karadag et al. found that 
bronchiectasis most commonly involved the lower lobes. Only one lobe was found to be 
diseased in 46%, bilobar involvement in 28.1%, and multilobar involvement in 31.9% 
(Karadag et al., 2005). Karakoc et al. found bronchiectasis affecting the left lower lobe in 
30.4%, and multilobar involvement in 56.5% (Karakoc et al., 2001).  Dogru et al. found the 
most common lobe affected by bronchiectasis was the left-lower lobe in the 204 children 
they evaluated (Dogru et al., 2005). Isolated upper lobe bronchiectasis generally relates to 
prior tuberculosis, bronchopulmonary aspergillosis, or bronchial obstruction. Overall, one-
third of cases of bronchiectasis are unilateral and affect a single lobe, one-third are unilateral 
but affect more than one lobe, and one-third are bilateral (Figure 1) (Deslauriers et al., 1998). 
 
 
Fig. 1. Chest CT scan showing bilateral cystic bronchiectasis in the lower lobes. 
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The middle lobe syndrome consists of a small atelectatic lobe, often owing to extrinsic 
bronchial compression secondary to enlarged peribronchial nodes (Deslauriers et al., 1998). 
The right middle lobe bronchus is long, often bends sharply at its bifurcation and is of 
relatively small caliber. A collar of lymph nodes also surrounds the proximal bronchus and 
any condition that causes a prolonged enlargement of these nodes may lead to obstruction 
and secondary bronchiectasis. This may also occur in malignancy and in nontuberculous 
mycobacterial infection (Figure 2) (Bertelsen et al., 1980; Levin, 2002). 
 
 
Fig. 2. Chest CT scan showing the bronchiectasis in the right middle lobe 
3. Etiology 
There have been a large number of factors that have been described as causative for 
bronchiectasis. A list of etiologic factors in different studies is given in Table 1. Recurrent 
pulmonary infection during childhood is an important factor in the etiology. Most of 
patients had recurrent infections in their histories and insufficient medication for pulmonary 
infection (Prieto et al., 2001; Agasthian et al., 1996; Fujimoto et al., 2001). The insufficient and 
inadequate use of medications for pulmonary infections and tuberculosis in patients, and 
the lack of follow-up over time, create a background for lung destruction (Figure 3). 
Bronchiectasis should not be mistaken with pseudo-bronchiectasis, temporary (up to 6 
months) cylindrical dilatation of the bronchi accompanying lung infection in children 
(Sirmali et al., 2006). In developing countries, tuberculosis is still one of the most important 
causes of bronchiectasis. Bronchiectasis commonly develops between 1 and 3 months after 
the initial infection and usually in the same pulmonary region (Karakoc et al., 2001; 
Haciibrahimoglu et al., 2004).   
Deficiencies in immune function, especially in humoral immunity, cause children to be at 
risk for recurrent sinopulmonary infections, which can lead to the development of 
bronchiectasis. This includes both primary immunodeficiency and secondary, or acquired, 
disease states (Boren et al., 2008). Cystic fibrosis is the most common cause of bronchiectasis 
among Caucasians of North America and Europe. Muco-ciliary clearance is a key defence 
mechanism against pulmonary infection. Its compromise is important in the development of 
the vicious cycle of bronchiectasis. The most prominent cilial disorder is primary ciliary 
dyskinesia which combines upper and lower respiratory tract infection, male infertility and 
in approximately 50%, situs inversus (King, 2009). Bronchial obstruction from either 
endobronchial pathology or external compression can also be an acquired factor 
predisposing to the development of bronchiectasis. Aspirated foreign bodies or gastric 
contents, slow-growing neoplasms, and mucous impaction can all cause local retention of 
secretions, secondary infection, and bronchiectasis (Deslauriers et al., 1998). 
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Etiolgic factor 
Balkanli 
n, % 
Eren 
n; % 
Sırmali 
n, % 
Cobanoglu 
n, % 
Giovannetti 
n, % 
Pneumonia 86 (36.1) 22 (15.3) 109 (61.9) 18 (29.0) 10 (22.2) 
Childhood infection 63 (26.4) 19 (13.2) - 7 (11.3) - 
Obstruction due to 
foreign body 
1 (0.4) 4 (2.7) 23 (13) 1 (1.6) - 
Pulmonary 
sequestration 
4 (1.6) 2 (1.4) - 4 (6.4) - 
Postobstructive 
pneumonitis 
- 34 (23.7) - 2 (3.2) - 
Measles - - - 4 (6.4) - 
Pertussis - - - 3 (4.8) 4 (8.8) 
Tuberculosis - 22 (15.3) 44 (25) 11 (17.7) 6 (13.3) 
Immunodeficiency  
(IgG, IgA) 
- - - 1 (1.6) - 
Cystic fibrosis - - - 2 (3.2) - 
Unknown etiology 84 (35.2) 40 (27.9) - 4 (6.4) 25 (55%) 
Table 1. Etiologic factors of bronchiectasis 
 
 
Fig. 3. Standart PA chest radigraph and Chest CT scan of a 4-year-old boy shows a 
destroyed left lung. 
4. Clinical presentation 
The clinical presentation of patients with bronchiectasis is variable and depends on the 
etiology of bronchiectasis and on whether the condition is localized of diffuse. Semptoms of 
the patients in different studies were presented in Table 2. The primary clinical symptom of 
bronchiectasis is a recurrent or permanent cough with ample sputum production. The 
sputum is frequently purulent and is often accompanied by hemoptysis in advanced stages 
of the disease (Nicotra et al., 1995). In the past, some bronchiectasis has been described as 
being nonproductive or “dry”, although in retrospect these were mostly cases of post-
tuberculous bronchiectasis located in the upper lobes (Deslauriers et al., 1998). Severe and 
life-threatening bleeding may result from erosions of the hypertrophic bronchial arteries or 
lesions in abnormal anastomoses between the pulmonary and bronchial arterial circulations. 
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Symptoms may be mild (eg, unproductive cough) or even absent if the disease is restricted 
to the upper lobes. Patients may also present with symptoms of the underlying disease that 
has led to the development of bronchiectasis (Zhang et al., 2010). Acute exacerbations of 
bronchiectasis are defined by symptomatic changes, including increased thick sputum 
production with change in color, shortness of breath, pleuritic chest pain, and generalized 
malaise. Chest roentgenograph (CXR) rarely shows new infiltrates, and the patient may lack 
fever and chills (Boren et al., 2008). 
 
Symptoms 
Balkanli 
n, % 
Eren 
n, % 
Zhang 
n, % 
Sirmali 
n, % 
Cobanoglu 
n, % 
Haciibrahimoglu 
n, % 
Productive cough 133 (55.8) 94 (65.7) 671 (85) 167 (94.9) 48 (77.4) 32 (91.4) 
Recurrence of 
pulmonary infection 
84 (35.2) 69 (48.2) - - 41 (66.1) 33 (94.2) 
Fetid sputum 116 (48.7) 72 (50.3) 277 (35) 139 (79) 27 (43.5) 28 (80) 
Hemoptysis 39 (12.1) 21 (14.6) 411 (52) 78 (44.3) 7 (11.3) 4 (11.4) 
Chest pain - 12 (8.3) 56 (7.1) - 7 (11.3) - 
Fatigue - - - - 17 (27.4) - 
Dyspnea - - - - 34 (54.8) - 
Growth retardation - - - 34 (19.3) - - 
Asymptomatic 10 (4.2) 2 (2.0) 25 (3.2) - 10 (16.1) - 
 
Table 2. Semptoms of the patients 
Physical examination is often nonspecific. Crepitation, wheezing, and coarse expiratory 
rhonchi may be heard over the lung bases, whereas clinical signs of cor pulmonale and 
denutrition are uncommon and indicate advanced disease. Routine clinical assessment 
should include a careful recording of personal and familial history, which may indicate an 
inherited disorder (Deslauriers et al., 1998). 
Pulmonary function testing can help determine the degree of lung damage because of 
bronchiectasis. Bronchiectasis typically results in obstructive lung function changes as the 
disease progresses. Typical obstructive changes on lung function testing include a reduced 
forced vital capacity (FVC), reduced forced expiratory volume in 1 s (FEV1), and reduced 
FEV1 to FVC ratio. Airway hyperresponsiveness with reversibility after the administration 
of inhaled bronchodilator should also be evaluated (Boren et al., 2008). 
5. Imaging 
Diagnosis of bronchiectasis is based on clinical history and imaging. CXR findings that are 
suggestive but nondiagnostic of bronchiectasis include stranding, cystic lesions, volume loss 
with crowding of vessels, air-fluid levels and honeycombing, and areas of infiltrates and 
atelectasis (Agasthian et al., 1996). Computed tomography scanning is currently the best 
technique to establish the presence, severity, and distribution of bronchiectasis, replacing 
Lipiodol bronchography, which is considered more invasive and more unpleasant to the 
patient as well as being occasionally associated with complications such as alveolitis or 
allergy to the local anesthetic agent or contrast medium. HRCT has replaced this procedure 
in the diagnosis of bronchiectasis, with only a 2% false negative and a 1% false positive rate 
(Young et al., 1991). The detailed images demonstrate bronchial dilatation, peribronchial 
inflammation, and parenchymal disease. 
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Perfusion isotopic lung scans using 99m Tc albumin particles in microspheres are 
considered important in the preoperative evaluation of patients with bronchiectasis because 
they may demonstrate abnormal territories considered normal on CT scans but representing 
potential areas of bronchial dilatations. This is explained by bronchial artery hyperplasia 
creating flow reversal through systemic to pulmonary artery shunting, thus causing areas of 
defective perfusion on the isotopic scan. Bronchial arteriography may be done to document 
the origin of hemoptysis. Esophageal studies if gastroesophageal reflux is suspected and 
ultrastructural examination of cilia from biopsy of the nasal respiratory epithelium if ciliary 
dyskinesia is suspected may be done (Deslauriers et al., 1998). 
6. Therapy for bronchiectasis  
Treatment options for the management of bronchiectasis include pharmacologic agents such 
as antibiotics, nonpharmacologic measures such as chest physiotherapy, and surgical 
procedures involving removal of the affected portion or portions of the lung. In general, 
treatment goals are to control infections and improve bronchial hygiene. General measures 
include avoidance of smoking and second-hand smoke, proper nutrition, and ensuring 
proper immunizations, including yearly influenza vaccinations. Depending on the specific 
cause of bronchiectasis, additional medical therapies may be warranted. This is especially 
true in patients with immunoglobulin deficiency, who could benefit from administration of 
intravenous or subcutaneous immunoglobulin for passive protection (Boren et al., 2008).  
The goals of surgical therapy for bronchiectasis are to improve the quality of life for those 
patients in which medical treatment has failed and to resolve complications such as 
empyema, severe or recurrent hemoptysis, and lung abscess (Agasthian et al., 1996; Annest 
et al., 1982). There is a broad consensus concerning the indications for surgical removal. The 
surgical treatment is based on two physiopathologic hypotheses. First, the resection involves 
removal of lung tissue with destroyed bronchi that are no longer functional. Second, it 
permits the removal of a localized area of bronchiectasis, which could otherwise be involved 
in the infectious contamination of adjacent territories (Mazieres et al., 2003). 
Mazierez and colleagues bring some arguments to help in the selection of patients who 
should be considered for operation (Mazieres et al., 2003). First, respiratory function and 
performance status must be compatible with the anesthetic risk. Second, the resection 
should be done quite early in the evolution of the disease because of the risk of 
contamination of healthy bronchi by an “active” territory and because of the low morbidity 
when the pulmonary function is good (Etienne et al., 1996). Third, operation is 
recommended for patients exhibiting disabling bronchiectasis with hemoptysis or a 
recurring infection that becomes resistant to medical treatment. Fourth, the etiology of 
bronchiectasis should not be considered in the decision for operation. Some studies showed 
the benefit of operation in primary ciliary dyskinesia (Simit et al., 1996), Kartagener’s 
syndrome (Figure 4) (Mazieres et al., 2003), and in hypogammaglobulinemia (Cohen et al., 
1994). Lastly, the ideal candidate has a nonhomogenous disease. Some territories are more 
severely involved and constitute real targets.  The removal of an active infectious territory 
may protect the healthy bronchi from infectious contamination. Removal of diseased 
segments can break the vicious circle as described by Cole and colleagues, and stop the 
progression of the disease (Cole et al., 1985). In children growth retardation due to 
bronchiectasis and drop in school attendance secondary to the illness should be included in 
the indications for surgery as well (Sirmali et al., 2006). 
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Fig. 4. Computed tomography scan showing the classic image of Kartagener’s syndrome 
caharacterized by dextrocardia and cylindrical bronchiectasis in the right upper lobe 
(patient’s left side). 
7. Preoperative preparation 
Careful preoperative preparations are of the utmost importance to reduce operation-related 
morbidity and mortality. The preoperative treatment should include reducing airway 
obstruction and elimination of microorganisms from the lower respiratory tract, which 
consists of antimicrobial therapy, postural physiotherapy, bronchodilators, and 
corticosteroids (Agasthian et al., 1996). Patients should be well prepared during the 
preoperative period with regard to infection to minimize postoperative complications. 
Bacterial infections, particularly those involving potentially necrotizing agents such as 
Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pneumonia, and various 
anaerobes, remain important causes of bronchiectasis, particularly when there is a delay in 
treatment or other factors that prevent eradication of the infection (Deslauriers et al., 1998). 
Antimicrobial therapy is particularly true in the setting of mycobacterial disease, such as M. 
tuberculosis and various environmental mycobacterial species. Patients with focal 
bronchiectasis and M. avium complex infection typically are started on a three-or four-drug 
regimen for 2-3 months before surgery based on in vitro susceptibility testing of the isolated 
organism. The regimen is continued through the hospital stay and for several months 
thereafter, often to a total of 24 months (Kim et al., 2005). 
Preoperative bronchoscopy should be routinely done to rule out benign or malignant cause 
of obstruction. Preoperative bronchoscopic examinations were performed in 117 (81.8%) of 
our patients as an adjuvant diagnostic method, to rule out benign or malignant bronchial 
obstruction, and for localization, collection of samples for microbiology, and bronchial toilet. 
We consider it essential in the preoperative evaluation and tracheobronchial cleaning of all 
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patients. In our study, patients in whom bronchoscopy was not performed had a 
significantly higher rate of postoperative complications (Eren et al., 2007). Patients should be 
preoperatively monitored until they produced less than 20 mL/day of sputum with little 
purulence. Operation should be not conducted until bronchofibroscopy showed no 
engorgement or edema in the tunica mucosa bronchiorum (Zhang et al., 2010). 
Most patients with chronic suppurative disease of the lungs are malnourished, often to a 
considerable degree, as a result of the long-standing catabolic state these patients 
experience. If malnutrition is present, an aggressive preoperative regimen of nutritional 
supplementation is advised (Sherwood et al., 2005). Pulmonary function studies should be 
preoperatively performed in all patients. The patients with bronchiectasis are showed a 
mixed or obstructive ventilatory pattern. In patients with low FEV1 (<60% of the predicted 
value) the postoperative complication rate was significantly high. This indicated that 
surgery should be delayed in cases of severe inflammation until adequate control has been 
achieved (Eren et al., 2007). 
In all patients undergoing pulmonary resection, it is imperative to clearly determine 
preoperatively the extent of resection to be done because at surgery it may be difficult to 
judge with great accuracy the segments that are involved. 
Balloon tamponade of the bleeding bronchus, which can be performed under emergency 
conditions is an effective method to manage massive hemoptysis in bronchiectasis patients. 
Embolization of the bronchial artery is a good alternative, capable of stopping the 
hemorrhage in 75—90% of the cases ( Freitag et al., 1994). On the other hand, once the first 
episode of hemorrhage is stopped, preoperative assessment should be promptly undertaken 
because recurrence in the first month after the embolization is frequent and fatal (Fujimoto 
et al., 2001; Mal et al., 1999). Planning surgical operation in patients with hemoptysis should 
involve bronchoscopic as well as radiological assessments. Yielding 2% false negative and 
1% false positive results, HRCT is a fairly reliable method for the diagnosis of bronchiectasis 
(Young et al., 1991). In such cases the most appropriate approach is to excise the 
pathological regions both depicted by HRCT and identified by bronchoscopy.  
8. Surgical technique 
A left-sided double-lumen endotracheal tube is used to avoid contralateral contamination of 
secretions. In children under 13 years old, in whom the double-lumen endotracheal tube is 
not used, bronchoscopy should be performed, and the bronchus of the side ready for 
resection should be cleaned by aspiration before the introduction of an endotracheal tube. A 
Fogarty embolectomy catheter may be used as a bronchus blocker in children (Eren et al., 
2007). A thoracic epidural catheter is employed when an open approach is planned based on 
the extent of resection. In patients in whom a thoracoscopic lobectomy or segmentectomy is 
performed, the epidural is omitted. An arterial line and urinary catheter are placed. 
Posterolateral thoracotomy or video-assisted thoracoscopic surgery (VATS) were performed 
for lung resection. Thoracotomy is performed so as to conserve as much muscle as possible. 
The resection type is selected according to the affected sides and cardiopulmonary reserve 
(Balkanli et al., 2003). Excessive bronchial dissection is avoided, and peribronchial tissues 
are preserved. The bronchial stump may manually be sutured with nonabsorbable materials 
or closed with a mechanical stapler. The bronchial stump is kept short. Stump covering with 
mediastinal pleura or tissue is performed. Complete resection is defined as an anatomic 
resection of all affected segments assessed preoperatively by either HRCT. Two silicon 
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drains are placed into the thoracic cavity before the thorax is closed. All resected specimens 
are examined histopathologically in order to confirm the diagnosis. At the end of the 
procedure, the bronchial suture is bronchoscopically checked, and secretions are removed 
from the airways. Patients are extubated in the operating room. When postoperative 
mechanical ventilation was necessary, a standard endotracheal tube is substituted for the 
double-lumen tube (Zhang et al., 20101). 
9. Complete resection and preserved segments 
Complete and anatomic resection should be done with preservation of as much lung 
function as possible to avoid cardiorespiratory limitation (Laros et al., 1988). It was reported 
that the symptoms persisted when incomplete resection was carried out (Campbell & Lilly, 
1982). We performed complete resection in 82.5% of our patients and preoperative 
symptoms resolved completely in 75.9% and improved in 15.7%, i.e. 92.8% benefited from 
the surgery. In the light of these findings, we suggest that complete resection should be 
performed for the surgical treatment of bronchiectasis and that incomplete resection should 
only be used for the palliative treatment of certain life-threatening symptoms. In our study, 
postoperative complications were observed in 11% of patients that underwent complete 
resection and in 80% of those that underwent incomplete resection (Eren et al., 2007). When 
suspicious lung regions are not excised with the aim of sparing as much lung tissue as 
possible, a second operation that carries a higher morbidity and mortality might be required 
to remove the residual diseased tissues (Sirmali et al., 2007). Therefore, we suggest that, 
during intraoperative examinations, if suspected areas that could not be determined by 
radiological examination are present, these parenchymal areas should be resected to 
perform complete resection and to decrease relapse rates. Bronchopulmonary development 
continues during childhood and the space occupied by the resected segments would be 
filled by the healthy lung segments. Therefore, surgeons should not refrain from wide 
resection of the lung to achieve complete resection of the diseased area (Sirmali et al., 2007). 
Incomplete resection should not be preferred in children except for palliative treatment of 
life threatening complications.  
The goal of surgery is to excise all diseased lung areas whenever possible and to preserve as 
much healthy lung parenchyma as possible. It is known that even 2 or 3 preserved segments 
can fill the hemithorax (Campbell & Lilly, 1982).  As recommended, we suggested to protect 
the anatomic structure of the superior segment in cases of bronchiectasis of the lower lobe 
when the superior segment of this lobe was normal (Fujimoto et al., 2001). In such patients, 
the superior segment had undergone a compensatory increase in volume and the affected 
basal segments had become small. Thus, the functional value of the superior segment was 
similar to that of the lower lobe (Yuncu et al., 2006). Patients with an uninvolved apical 
segment were found to have better spirometric values than those with more extensive 
disease (Ashour et al., 1996). 
10. Resection for multisegmental bilateral bronchiectasis 
Surgical treatment is usually offered only when the diseased area is well localized and 
restricted to one or several segments within the same lobe. Multiple or bilateral bronchiectasis 
is generally regarded as a contraindication to operation. From the end of the 1970s onward, 
some thoracic surgeons have suggested that bilateral bronchiectasis is not a contraindication to 
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resection (George et al., 1979; Fujimoto et al., 2001). Nevertheless, the patients reported in the 
literature remained quite rare. The therapeutic options in nonfocal bronchiectasis are limited. 
Most of the time patients are treated with antibiotics and physiotherapy. Recently, progress 
has been made with the use of new antibiotics and inhalation of tobramycin solution in cases 
of Pseudomonas aeruginosa colonization (Barker et al., 2000). These therapies allow a good 
quality of life and symptomatic improvement for several years, but the usual evolution is a 
progression toward chronic respiratory failure with a poor prognosis and selection of resistant 
strains (Annest et al., 1982; Keistinen et al., 1997). Transplantation remains indicated for 
homogenous disease and for patients with advanced disease with seriously compromised 
pulmonary function and chronic respiratory failure (Hasan et al., 1995). The 3-year survival 
rate is 75% for patients undergoing double-lung transplantation (Barlow et al., 2000). Some 
investigators have proposed a radical operation for bilateral bronchiectasis (Kittle et al., 1985; 
Laros et al., 1988) but others report a higher mortality with pneumonectomy (McGovern et al., 
1988). Considering the limited and palliative effect of medical treatment and the risk of 
transplantation or radical operation, it seems that a limited operation should be offered to 
some patients with diffuse bronchiectasis. 
Mazierez and collegues suggested that surgical indications were offered to patients with 
multisegmental and severe bronchiectasis if (1) optimal medical treatment and physiotherapy 
were no longer efficient, (2) bleeding and sputum production were recurrent and abundant, (3) 
severely damaged territories could be identified, and (4) performance status and pulmonary 
function were compatible with the anesthetic risk (Mazierez et al., 2003). 
Surgery in multiple segments on different lobes is technically more difficult, resulting in 
higher morbidity and mortality.21 However, pulmonary resection is indicated early in 
patients with multisegmentar bronchiectasis, before other portions of the lung become 
grossly diseased. Our purpose in these patients was to protect as much pulmonary function 
as possible, with the aim of removing only the affected areas of different lobes. The types of 
procedures in different studies were presented in Table 3. 
 
Operation type 
Balkanli  
n, % 
Eren 
n; % 
Zhang 
n, % 
Sırmali 
n, % 
Haciibrahimoglu 
n, % 
Giovannetti 
n, % 
Pneumonectomy 13 (5.4) 12  (8.3) 90 (11.3) 40 (19.9) 7 (20) 1 (1.7) 
Lobectomy 189 (79.4) 82 (55.4) 497 (62.9) 90 (44.7) 17 (48.5) 33 (56.8) 
Bilobectomy  7 (4.7) 56 (7.1) 21 (10.4) 2 (5.7) 2 (3.4) 
Lobectomy & 
segmentectomy 
31 (13.0) - 110 (14) - 5 (14.2) 11 (18.9) 
Lobectomy & 
lingulectomy 
 -  34 (16.9) -  
Segmentectomy 10 (4.2) 17 (11.4) 37 (4.7) 16 (7.9) 4 (11.4) 11 (18.9) 
Basal segmentectomy - 16  (10.8) - - - - 
Basal segmentectomy & 
lingulectomy 
- 5 (3.3) - - - - 
Basal segmentectomy & 
middle lobectomy 
- 4 (2.7) - - - - 
 
Table 3. Type of operation 
11. Video-assisted thoracoscopic surgery  
VATS for major lung resection has become a more frequent procedure in recent years with 
promising outcome. VATS represents a new approach; the indications for VATS major 
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resection remain the same as for conventional resection. But not all the patients with 
bronchiectasis who needed operations were suitable for VATS lobectomy; severe scarring 
and adhesions on computed tomographic scan should be considered . The severity of 
adhesions to the chest wall, the hilum, and especially in the fissure, typically seen in 
inflammatory disease, was the key limiting factor for a safe VATS lobectomy (Weber et al., 
2001). Adhesions need to be dissected to explore the relevant anatomy. If there were dense 
adhesions (such as destroyed lobes mainly after tuberculosis with or without aspergillosis) 
or enlarged lymph nodes, especially calcified, open operations were required (Zhang et al., 
2011). 
Bronchiectasis was considered the best lung benign disease suitable for VATS lobectomy 
(Yim, 2002). The VATS major resection has demonstrated to be a safe procedure when 
performed by experienced physicians. Postoperative pain after VATS is uncommon as 
compared with open surgery. Other documented advantages include better preservation of 
pulmonary function in the early postoperative period, earlier return to full activities, and 
better quality of life after recovery. One major advantage of VATS resection is that it allows 
recruitment of older and sicker patients with multiple comorbidities who would otherwise 
not be candidates for resection through a conventional thoracotomy approach (Farjah et al., 
2009; Gonzales-Aragoneses et al., 2009). In study of Zhang and collegeus, the patients with 
VATS had a shorter length of stay in the hospital, fewer complications, and less pain in the 
postoperative period than those with thoracotomies (Zhang et al., 2011). 
12. Postoperative complication 
Bronchiectasis is an inflammatory disease of the lungs and the risk of developing 
postoperative empyema is higher than in other cases. Empyema, on the other hand, is a risk 
factor for bronchopleural fistula (Sirmali et al., 2006). Therefore, we suggest reinforcement of 
the bronchial stump in all patients. Bronchopleural fistula can be observed in as many as 
9.1% of the cases (Fujimoto et al., 2001). Fujimoto and colleagues argued that the bronchial 
stump should be reinforced when the inflammation in the lung of bronchiectasis patients 
could not be effectively controlled (Fujimoto et al., 2001). We, however, suggest 
reinforcement the bronchial stump in all cases. Additionally, to avoid empyema, we 
recommend postoperative bacterial culture of thoracic effusion if the remaining lung shows 
signs of persisting inflammation. Sputum retention is common because patients with this 
disease might have problems with ciliary motion and postoperative expectoration, which 
would be easily disrupted (Fujimoto et al., 2001). In our series, respiratory physiotherapy 
was re-initiated on the first post-operative day, and continued for 2 weeks after discharge. 
We used bronchoscopy for sputum aspiration during the early postoperative period if 
physiotherapy was not effective. Virtually all patients had specific or large-spectrum 
intravenous antibiotic therapy for 1 week (Eren et al., 2007).  
In bronchopleural fistula, drainage of the infected space is a key initial step to limit damage 
to the remaining lung. Bronchopleural fistula noted very early after the initial resection may 
be treated with primary reclosure and rebuttressing of the stump; later bronchopleural 
fistula usually require rib resection and creation of an Eloesser flap, followed by 
bronchopleural fistula closure and subsequent Clagett procedure, for successful treatment 
(Sugarbaker et al., 2009). The presence of a significant intrathoracic "space" appears to be 
more common after major lung resection for infectious lung disease such as bronchiectasis 
compared with other indications for surgery. The use of transposed muscle such as 
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latissimus dorsi minimizes the potential complications in this setting, including 
postresection empyema or prolonged air leak (Sugarbaker et al., 2009). The rate of 
complications in the current literature varies between 9.4% and 24.6%. Mortality ranges 
from 0% to 8.3% in the literature (Fujimoto et al., 2001). Postoperative complications in 
different studies were presented in Table 4. 
 
Complication 
Balkanli 
n, % 
Eren 
n, % 
Zhang 
n, % 
Sırmali 
n, % 
Cobanoglu 
n, % 
Haciibrahimoglu 
n, % 
Giovannetti 
n, % 
Postoperative 
Pneumonia 
- 3 (2.0) 24 (3) 3 (1.7) - 3 (8.8) 2 (4.4) 
Atelectasis 7 (2.9) 11 (7.6) 16 (2) 8 (4.5) 4 (6.4) -  
Prolonged air-leak 6 (2.5) 7 (4.8) 21 (2.7) 3 (1.7) 2 (3.2) 1 (2.9) 1 (2.2) 
Residual 
air-space 
- - - - - - 1 (2.2) 
Sputum retention - - - - - - 1 (2.2) 
Bronchial 
infection 
- - - - - - 1(2.2) 
Bronchopleural 
fistula 
2 (0.8) - 3 (0.4) - 2 (3.2) - - 
Postoperative 
hemorrhage 
4 (1.6) 2 (1.3) 9 (1.1) 2 (1.1) 1 (1.6) - - 
Empyema 2 (0.8) 5 (3.4) 5 (0.6) 5 (2.8) 2 (3.2) 2 (5.8) - 
Severe 
supraventricular 
arrhythmias 
- 3 (2.0) 32 (4) - 1 (1.6) - - 
Respiratory  
insufficiency 
- 2 (1.3) 10 (1.3) - - - - 
Total 21 (8.8) 33 (23) 128 (16.2) - - 6 (17.6) 6 (13.2) 
 
Table 4. Postoperative complications 
13. Conclusion 
Bronchiectasis is pathologically defined as a condition in which there are abnormal and 
permanent dilatations of proximal bronchi. Bronchiectasis can occur as focal or localized 
disease, or in a diffuse manner. Overall, one-third of cases of bronchiectasis are unilateral 
and affect a single lobe, one-third are unilateral but affect more than one lobe, and one-third 
are bilateral. Recurrent pulmonary infection during childhood is an important factor in the 
etiology. In developing countries, tuberculosis is still one of the most important causes of 
bronchiectasis. Bronchial obstruction from either endobronchial pathology or external 
compression can also be an acquired factor predisposing to the development of 
bronchiectasis.  
Treatment options for the management of bronchiectasis include pharmacologic agents such 
as antibiotics, nonpharmacologic measures such as chest physiotherapy, and surgical 
procedures involving removal of the affected portion or portions of the lung. The goals of 
surgical therapy for bronchiectasis are to improve the quality of life for those patients in 
which medical treatment has failed and to resolve complications such as empyema, severe or 
recurrent hemoptysis, and lung abscess.  The preoperative treatment should include 
reducing airway obstruction and elimination of microorganisms from the lower respiratory 
tract, which consists of antimicrobial therapy, postural physiotherapy, bronchodilators, and 
corticosteroids.  Preoperative bronchoscopy should be routinely done to rule out benign or 
malignant cause of obstruction. 
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Complete and anatomic resection should be done with preservation of as much lung 
function as possible to avoid cardiorespiratory limitation. It was reported that the symptoms 
persisted when incomplete resection was carried out. When suspicious lung regions are not 
excised with the aim of sparing as much lung tissue as possible, a second operation that 
carries a higher morbidity and mortality might be required to remove the residual diseased 
tissues. Therefore, we suggest that, during intraoperative examinations, if suspected areas 
that could not be determined by radiological examination are present, these parenchymal 
areas should be resected to perform complete resection and to decrease relapse rates.  
Surgery in multiple segments on different lobes is technically more difficult, resulting in 
higher morbidity and mortality. However, pulmonary resection is indicated early in patients 
with multisegmentar bronchiectasis, before other portions of the lung become grossly 
diseased. Our purpose in these patients was to protect as much pulmonary function as 
possible, with the aim of removing only the affected areas of different lobes. VATS 
represents a new approach; the indications for VATS major resection remain the same as for 
conventional resection. But not all the patients with bronchiectasis who needed operations 
were suitable for VATS lobectomy; severe scarring and adhesions on computed 
tomographic scan should be considered. When necessary, surgical treatment of 
bronchiectasis can be performed with acceptable morbidity and low mortality. 
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